Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted contrast agents in MR imaging

H Gupta1, R Weissleder

  • 1MR Pharmaceutical Program, MGH-NMR Center, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.

Magnetic Resonance Imaging Clinics of North America
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models.

Nature biotechnology·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

Cardiovascular Magnetic Resonance: Innovation, Integration, and Clinical Impact.

Magnetic resonance imaging clinics of North America·2026
Same journal

Advances and Innovations in Cardiovascular Magnetic Resonance.

Magnetic resonance imaging clinics of North America·2026
Same journal

The Future of Cardiac Magnetic Resonance: Navigating Ultra-High and Low-Field Imaging (Part 2).

Magnetic resonance imaging clinics of North America·2026
Same journal

Artificial Intelligence Applications in Cardiac MR Imaging.

Magnetic resonance imaging clinics of North America·2026
Same journal

Climate Change and Globally Sustainable Cardiovascular Magnetic Resonance.

Magnetic resonance imaging clinics of North America·2026
Same journal

Strain Imaging in Heart Failure.

Magnetic resonance imaging clinics of North America·2026
See all related articles

Target-specific magnetic resonance (MR) contrast agents enhance MR imaging by combining specialized carriers with magnetic labels. This review explores their components and promising clinical uses in medical diagnostics.

Area of Science:

  • Biomedical Imaging
  • Nanotechnology
  • Radiochemistry

Background:

  • Magnetic resonance (MR) imaging provides valuable diagnostic information.
  • Conventional MR contrast agents offer non-specific enhancement.
  • Target-specific agents aim to improve diagnostic accuracy and information yield.

Purpose of the Study:

  • To review the components of target-specific MR contrast agents.
  • To discuss various carrier molecules and magnetic labels used.
  • To highlight promising clinical applications of these advanced agents.

Main Methods:

  • Literature review of target-specific MR contrast agent development.
  • Categorization of agents based on carrier types (e.g., antibodies, peptides, polymers, liposomes).

Related Experiment Videos

  • Analysis of magnetic label types (e.g., metal chelates, iron oxides).

    • Main Results:

    • Target-specific MR contrast agents integrate diverse carriers with magnetic labels.
    • Components include antibodies, peptides, proteins, polysaccharides, polymers, liposomes, cells, metal ion chelates, free radicals, and iron oxides.
    • Significant potential for improved diagnostic capabilities in clinical settings.

    Conclusions:

    • Target-specific MR contrast agents represent a significant advancement in MR imaging.
    • Their tailored design allows for enhanced information retrieval.
    • Clinical applications are rapidly evolving, promising improved disease detection and characterization.